Safety and efficacy of 25-hydroxycholecalciferol as a feed additive for poultry and pigs

被引:8
|
作者
不详
机构
来源
EFSA JOURNAL | 2009年 / 7卷 / 02期
关键词
nutritional additive; vitamin D; 25-hydroxycholecalciferol; calcifediol; poultry; pigs; safety; efficacy;
D O I
10.2903/j.efsa.2009.969
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of 25-hydroxycholecalciferol (E 670 a) as feed additive for poultry and pigs. This additive is already authorised for use without a time limit in chickens for fattening, turkeys and laying hens. The applicant is now asking for a re-evaluation of the existing authorisation and for an extension of the authorisation to all poultry and pigs. The additive ROVIMIX (R) Hy center dot D (R) 1.25% contains 12.5 g 25-OH-D3 kg(-1) as active substance, which is a physiological precursor of the vitamin D3 active hormone. 25-OH-D3 from ROVIMIX (R) Hy center dot D (R) 1.25% is efficacious in all poultry species and pig categories when substituting for vitamin D3 in feed. ROVIMIX (R) Hy center dot D (R) 1.25% is considered safe for the target animals at maximum contents of 0.100 mg 25-OH-D3 kg(-1) complete feed for chickens and turkeys for fattening, of 0.080 mg 25OH-D3 kg(-1) complete feed for all other poultry species and of 0.050 mg 25-OH-D3 kg(-1) for all pig categories. After reassessing the in vivo toxicological studies on laboratory animals submitted, the FEEDAP Panel confirms its earlier conclusions that the 'effects seen in the toxicity studies which have been conducted are entirely consistent with a physiological overload of Vitamin D or its metabolites and are not indicative of any unexpected toxicity arising from the source or production method of the substance.' There is no new information which would require a modification of the formerly proposed UL of 10 mu g 25-OH-D-3 adult person(-1) day(-1) and 5 mu g 25-OH-D3 child(-1) day(-1). Exposure calculation of the consumer was based on former tissues and product deposition data in poultry and new data in pigs. The total intake was estimated to amount to 6.9 mu g 25-OH-D-3 person(-1) day(-1). This value complies with the provisional UL for adults (69 %) but is above that for children (138 %, based on the intake of adults). Refined calculation (more realistic consumption data) reduced the estimated exposure to 2.44 mu g 25-OH-D-3 person(-1) day(-1), which is below the provisional UL for both the adults (24 %) and the children (49 %). The FEEDAP Panel concludes that the total exposure resulting from the use of 25-OH-D-3 in all poultry species and pig categories, at the proposed maximum doses, would not present a risk for the consumer. The additive ROVIMIX (R) Hy center dot D (R) 1.25% is not irritant to the skin or eye. Data on sensitisation as well as on respiratory toxicity were not provided. The most likely route of workplace exposure to 25-OH-D3 is by inhalation. A worst case calculation scenario results in a potential daily inhalation of about 4 mu g for workers preparing premixtures containing ROVIMIX (R) Hy center dot D (R) 1.25%. This figure is included in the part of the UL not covered by food consumption. The use of 25-OH-D-3 in feedingstuffs does not represent a risk for the environment. The FEEDAP Panel has made some recommendations concerning the specification of the additive, focusing on the safety of the 25-OH-D-3 formulation for the target animals and the user.
引用
收藏
页数:32
相关论文
共 50 条
  • [31] 25-HYDROXYCHOLECALCIFEROL AND FRACTURES OF PROXIMAL FEMUR
    LUND, B
    SORENSEN, OH
    CHRISTENSEN, AB
    LANCET, 1975, 2 (7929): : 300 - 302
  • [32] CHICKS REQUIREMENT FOR 25-HYDROXYCHOLECALCIFEROL AND CHOLECALCIFEROL
    MCNAUGHTON, JL
    DAY, EJ
    DILWORTH, BC
    POULTRY SCIENCE, 1977, 56 (02) : 511 - 516
  • [33] 25-HYDROXYCHOLECALCIFEROL LEVELS IN BEDOUINS IN NEGEV
    SHANY, S
    HIRSH, J
    BERLYNE, GM
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1976, 29 (10): : 1104 - 1107
  • [34] ACUTE ADMINISTRATION OF 25-HYDROXYCHOLECALCIFEROL IN MAN
    HADDAD, JG
    ROJANASATHIT, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (02): : 284 - 290
  • [35] Safety and efficacy of a feed additive consisting of 25-hydroxycholecalciferol monohydrate produced with Saccharomyces cerevisiae CBS 146008 for all ruminants (DSM Nutritional Products Sp. z.o.o.)
    Bampidis, Vasileios
    Azimonti, Giovanna
    Bastos, Maria de Lourdes
    Christensen, Henrik
    Dusemund, Birgit
    Durjava, Mojca
    Kouba, Maryline
    Lopez-Alonso, Marta
    Puente, Secundino Lopez
    Marcon, Francesca
    Mayo, Baltasar
    Pechova, Alena
    Petkova, Mariana
    Ramos, Fernando
    Sanz, Yolanda
    Villa, Roberto Edoardo
    Woutersen, Ruud
    Gropp, Jurgen
    Anguita, Montserrat
    Galobart, Jaume
    Pettenati, Elisa
    Pizzo, Fabiola
    Vettori, Maria Vittoria
    Tarres-Call, Jordi
    EFSA JOURNAL, 2023, 21 (08)
  • [36] CLINICAL EXPERIENCES WITH A 25-HYDROXYCHOLECALCIFEROL ASSAY
    SMITH, HC
    TORKINGTON, P
    TREVILLIAN, PR
    POSEN, S
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 (03): : 251 - 251
  • [37] 25-HYDROXYCHOLECALCIFEROL DYNAMICS IN HUMAN PLASMA
    BEC, P
    BAYARD, F
    LOUVET, JP
    REVUE EUROPEENNE D ETUDES CLINIQUES ET BIOLOGIQUE, 1972, 17 (08): : 793 - &
  • [38] MEASUREMENT OF PLASMA 25-HYDROXYCHOLECALCIFEROL IN MAN
    BAYARD, F
    BEC, P
    LOUVET, JP
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1972, 2 (04) : 195 - &
  • [39] Efficacy of different limestone particle size and 25-hydroxycholecalciferol in broiler diets
    Koreleski, J
    Swiatkiewicz, S
    JOURNAL OF ANIMAL AND FEED SCIENCES, 2005, 14 (04): : 705 - 714
  • [40] CLINICAL EXPERIENCES WITH A 25-HYDROXYCHOLECALCIFEROL ASSAY
    SMITH, HC
    TORKINGTON, P
    TREVILLIAN, PR
    POSEN, S
    NEW ZEALAND MEDICAL JOURNAL, 1976, 84 (570) : 161 - 162